InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Besthof Robert, Directeur de la communication et des patients. Director active across 1 companies, notably NRX Pharmaceuticals, Inc.. Cumulatively, 2 filings have been logged. The latest transaction was filed on 16 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€10,81763,710 shares@ €0.1698100.0% of flow
Common Stock
SEC:0000950142-21-003503·
€10,81763,710 shares@ €0.169850.0% of flow
Common Stock
SEC:0000950142-21-003503:0·
2 of 2 declarations
About Besthof Robert
Robert Besthof is the Chief Communication & Patient Officer at NRX Pharmaceuticals, Inc. In this role, he is responsible for the company's communication strategy and patient engagement. His expertise in communication enables him to play a key role in promoting the company's initiatives and enhancing the patient experience. Robert is committed to ensuring clear and effective communication between NRX Pharmaceuticals and its stakeholders.
